Skip to content

Study on comprehensive intervention strategy of TCM in chronic obstructive pulmonary disease

Study on comprehensive intervention strategy of TCM in chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002345
Enrollment
Unknown
Registered
2019-05-18
Start date
2019-05-22
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients meeting the diagnostic criteria of COPD; (2) stable patients with grade I or II disease; (3) aged 40 to 80 years; (4) those who did not participate in the clinical study of other interventions in the first 3 months; (5) voluntarily accept treatment and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with acute exacerbation COPD; (2) stable patients with grade III or IV COPD; (3) pregnant and lactating women; (4) delirium, dementia and various mental diseases; (5) patients with severe cardiac dysfunction and hemodynamic instability; (6) patients with bronchiectasis, bronchial asthma, mobile tuberculosis, occlusive bronchiolitis, diffuse bronchiolitis; Combined with pulmonary embolism, pneumothorax and pleural effusion; Concomitant tumors; (7) neuromuscular diseases affecting respiratory motor function; (8) severe hepatorenal diseases, such as cirrhosis, portal hypertension and varicose bleeding; Dialysis and kidney transplantation; (9) long-term bedridden patients; (10) oral glucocorticoid administration within 1 month before inclusion; (11) congenital or acquired immunodeficiency; (12) participants in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
The frequency and severity of acute exacerbations of COPD;

Secondary

MeasureTime frame
Improved lung function;Quality of life;Patient satisfaction;

Countries

China

Contacts

Public ContactMaYan

Tianjin University of Traditional Chinese Medicine

freida@163.com+86 13502195541

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026